Holdings A/S Novo - Jun 16, 2021 Form 3 Insider Report for Verve Therapeutics, Inc. (VERV)

Role
10%+ Owner
Signature
/s/ Peter Haahr, Chief Financial Officer of Novo Holdings A/S
Stock symbol
VERV
Transactions as of
Jun 16, 2021
Transactions value $
$0
Form type
3
Date filed
6/16/2021, 05:18 PM
Previous filing
Jun 3, 2021
Next filing
Jun 17, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding VERV SERIES B CONVERTIBLE PREFERRED STOCK Jun 16, 2021 COMMON STOCK 443K Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share of Series B Convertible Preferred Stock will convert automatically into one share of common stock upon the closing of the Issuer's initial public offering. These shares have no expiration date.